ArticleClinical drug investigation2024

Evaluation of the Effectiveness of Additional Risk Minimisation Measures for Tofacitinib (Xeljanz

Joanne Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.